Lyell Immunopharma

Lyell Immunopharma is a clinical-stage company advancing next-generation CAR T-cell product candidates for patients with cancer. The company is building an industry-leading pipeline based on deep understanding of T-cell biology and its interaction with cancer. It owns and operates the LyFE Manufacturing Center in Bothell, Washington, capable of manufacturing more than 1,200 patient CAR T-cell products a year at full capacity. The company was founded by cell therapy pioneers, and its leadership team includes industry veterans.

Lyell Immunopharma is a clinical-stage company advancing next-generation CAR T-cell product candidates for patients with cancer. The company is building an industry-leading pipeline based on deep understanding of T-cell biology and its interaction with cancer. It owns and operates the LyFE Manufacturing Center in Bothell, Washington, capable of manufacturing more than 1,200 patient CAR T-cell products a year at full capacity. The company was founded by cell therapy pioneers, and its leadership team includes industry veterans.

1. Next-Generation CAR-T Cell Therapies for Cancer | Lyell
2. Clinical-stage Cell Therapy Company | About Lyell
3. Our Leadership | Lyell
4. Lyell Immunopharma (United States)